Pharmacyte BiotechPMCB
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 28 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, up 5 from Q3 2025. 7 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($166K), HRT Financial LP ($132K) and Geode Capital Management, LLC ($90K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $248K |
| Exits | 1 | $1 |
All 13F filers, Q3 2025 → Q4 2025: 614,977 shares bought and 64,167 shares sold, net +550,810 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Citadel Advisors | 0.00% | Add +1480.9% | 229,722 | $166K |
| HRT Financial LP | 0.00% | New | 182,801 | $132K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.2% | 123,844 | $90K |
| Sabby Management, LLC | 0.61% | New | 100,000 | $72K |
| Renaissance Technologies | 0.00% | Add +17.6% | 94,036 | $68K |
| Vanguard Group Inc. | 0.00% | No change | 74,919 | $54K |
| Northern Trust Corp. | 0.00% | Add +85.3% | 35,601 | $26K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -0.1% | 26,178 | $19K |
| Simplex Trading, LLC | 0.00% | Add +2248.6% | 25,834 | $19K |
| Two Sigma Securities, LLC | 0.00% | New | 24,553 | $18K |
| XTX Topco Ltd | 0.00% | New | 24,442 | $18K |
| Equitec Proprietary Markets, LLC | 0.08% | Reduce -73.1% | 22,227 | $16K |
| Jane Street Group, LLC | 0.00% | New | 11,391 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -11.8% | 4,898 | $4K |
| UBS Group AG | 0.00% | Add +107.6% | 2,746 | $2K |
| Bank of America Corp. | 0.00% | Reduce -41.6% | 314 | $227 |
| Osaic Holdings, Inc. | 0.00% | Reduce -0.3% | 303 | $219 |
| Sachetta, LLC | 0.00% | No change | 14 | $11 |
| Aviso Financial Inc. | 0.00% | New | 12 | $8 |
| Bfsg, LLC | 0.00% | No change | 5 | $4 |
| Morgan Stanley | 0.00% | Reduce -77.8% | 2 | $2 |
| Financial Consulate, Inc. | 0.00% | No change | 2 | $2 |
| MCF Advisors LLC | 0.00% | New | 1 | $1 |
| NewEdge Advisors, LLC | 0.00% | No change | 2 | $1 |
| IFP Advisors, Inc | 0.00% | No change | 1 | $1 |
| BlackRock, Inc. | 0.00% | No change | 1 | $1 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
| Covestor Ltd | 0.00% | No change | 275 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.